Form 4 for TARS Tarsus Pharmaceuticals, Inc.
Accepted 2026-01-14 00:00:00 ET · period of report 2025-12-15 · accession 0002044770-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-14 | 2025-12-15 | TARS | Goodrich Katherine | Dir | M - OptEx | — | +2,233 | 2,233 | New | — |
| D | 2026-01-14 | 2025-12-15 | TARS | Goodrich Katherine | Dir | M - OptEx | $0.00 | -2,233 | 4,467 | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-15 | M | A | 2,233 | — | 2,233 | D | — | — | (F1) The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. |
| 2 | Derivative | Restricted Stock Units | 2025-12-15 | M | D | 2,233 | $0.00 | 4,467 | D | — · — to — | 2,233 Common Stock | (F2) Each RSU represents a contingent right to receive one share of the Company's common stock. (F3) The RSUs will vest in three equal installments on December 15th of 2025, 2026 and 2027, subject to the Reporting Person's continuous service. |